AB0387 SATISFACTION OF PATIENTS AND PHYSICIANS WITH TREATMENTS FOR RHEUMATOID ARTHRITIS: A NATIONWIDE SURVEY IN CHINA

Background Treatment satisfaction is important for adherence to therapy both for patients and physicians. There is no full understanding of the treatment satisfaction for rheumatoid arthritis (RA) in China. Objectives The aim is to explore the treatment satisfaction between rheumatologists and RA patients across China and the factors associated with patients’ satisfaction. Methods We conducted a prospective, multicenter, observational study of physicians and patients in 12 centers from 11 provinces across China between March and April 2018 (NCT03483597). The Treatment Satisfaction Questionnaire for Medication version II (TSQM-II) was used to assess the treatment satisfaction of patients and physicians regarding to csDMARDs and bDMARDs therapy. Multiple linear regression analysis was used to determine the factors independently associated with patients’ satisfaction. Results 1237 patients (82.5% female) with a mean age (SD) of 48.9 (13.4) years and 146 rheumatologists (72.6% working>5 years) were included in this survey. The patients’ satisfaction (n=335) with bDMARDs was higher than physicians’ satisfaction (n=146) regarding the side effects (95.0±14.3 vs. 84.6±15.7, p Conclusion For bDMARDs, the treatment satisfaction of patients with RA is generally better than that of physicians. Physicians’ satisfaction with bDMARDs is higher than that with csDMARDs. The independently factors associated with the treatment satisfaction of patients with RA are age, education, disease severity, the patient-physician communication, and treatment costs, which could be targeted in routine clinical care. References None Acknowledgement The authors acknowledge contributions from the HealthCloud Co., Ltd as the system provider. Disclosure of Interests None declared